Cite
HARVARD Citation
Tan, D. et al. (n.d.). EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects. International journal of gynecological cancer. p. A172. [Online].